Results 31 to 40 of about 378,540 (249)
Relapse of Juvenile Dermatomyositis following Eight Years in Remission: A Case Report. [PDF]
Book J, Theriot T, Joseph J, Haas C.
europepmc +3 more sources
Comprehensive Analysis Reveals Potential Molecular Targets in Juvenile Dermatomyositis. [PDF]
Chen C, Qiao H.
europepmc +2 more sources
Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis. [PDF]
Windschall D +4 more
europepmc +2 more sources
As the most common idiopathic inflammatory myopathy in children, juvenile dermatomyositis (JDM) is characterized by skin rashes and muscle weakness.
Kanglei Zhou +9 more
semanticscholar +1 more source
CORRELATIONS BETWEEN NAILFOLD CAPILLAROSCOPY FINDINGS AND DISTINCT CLINICAL FORMS OF JUVENILE DERMATOMYOSITIS [PDF]
Juvenile dermatomyositis is the most common idiopathic inflammatory myopathy in childhood. Nailfold capillaroscopy plays an important role in its assessment, being useful for diagnosis and follow-up.
Sigrid Covaci +2 more
doaj +1 more source
Objectives: To elucidate mechanisms contributing to skeletal muscle calcinosis in patients with juvenile dermatomyositis. Methods: A well-characterized cohorts of JDM (n = 68), disease controls (polymyositis, n = 7; juvenile SLE, n = 10, and RNP ...
Bhargavi Duvvuri +11 more
semanticscholar +1 more source
Objectives Juvenile dermatomyositis (JDM) is a chronic autoimmune disease. Some patients remain in an active state even though they were administrated with a combination of corticosteroid and methotrexate.
Junmei Zhang +13 more
semanticscholar +1 more source
Background We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with disease damage in children with newly ...
L. Pachman +4 more
semanticscholar +1 more source
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy
This open‐label, 24‐week study was conducted to evaluate the safety and efficacy of abatacept in patients with refractory juvenile dermatomyositis (DM).
R. Curiel +10 more
semanticscholar +1 more source
Juvenile dermatomyositis (JDM) is a rare condition, which causes inflammation in children’s skin and musculoskeletal systems. Symptoms include characteristic skin rashes on the face and extremities, muscle pain and weakness. This is a case report of a ten-year-old boy initially suspected of having lupus erythematosus. He was later diagnosed with JDM by
Vigand Svendsen, Sebastian +3 more
openaire +2 more sources

